Person:
BAYRAM, FERİT

Loading...
Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

BAYRAM

First Name

FERİT

Name

Search Results

Now showing 1 - 2 of 2
  • PublicationOpen Access
    Effect of submucosal application of tramadol on postoperative pain after third molar surgery
    (BIOMED CENTRAL LTD, 2015-12) BAYRAM, FERİT; Gonul, Onur; Satilmis, Tulin; Bayram, Ferit; Gocmen, Gokhan; Sipahi, Aysegul; Goker, Kamil
    The aim of this study was to evaluate the effectiveness of submucosal application of tramadol, for acute postoperative facial pain, following the extraction of impacted third molar teeth. This prospective, double-blind, randomised placebo-controlled study included 60 ASA I-II patients undergoing impacted third molar surgery under local anaesthesia. Following the surgical procedure, patients were randomly divided into two groups; group T (1 mg/kg tramadol) and group S (2-mL saline). Treatments were applied submucosally after surgery. Pain after extraction was evaluated using a visual analogue scale (VAS) 0.5, 1, 2, 4, 6, 12, 24, and 48 h postoperatively. The time at which the first analgesic drug was taken, the total analgesic dose used, and adverse tissue reactions were also evaluated. In group T, postoperative VAS scores were significantly lower compared to that in group S (p < 0.05). This study demonstrated that post-operative submucosal application of tramadol is an effective method for reducing acute post-operative facial pain after impacted third molar surgery.
  • Publication
    Influence of a Biodegradable Synthetic Hydrogel Used as a Guided Bone Regeneration Membrane in Sinus Floor Augmentation
    (MARMARA UNIV, INST HEALTH SCIENCES, 2018) BAYRAM, FERİT; Bayram, Ferit; Gocmen, Gokhan; Ozkan, Yasar
    Objective: The purpose of this study is to compare the clinical, histological, and radiological aspects of the polyethylene glycol (PEG) hydrogel membrane and the standard collagen membrane in sinus floor augmentation procedures when the same bone filling material is used. Methods: Fourteen patients (5 men and 9 women) were included in this prospective cohort study. Twenty sinus floor augmentation surgeries were randomly divided into two groups: the study group (n=10) and the control group (n=10). An anorganic bovine graft (Bio-Oss (R), Geistlich Pharma AG, Switzerland) was used in all patients as the bone-filling material. As a protective membrane, a collagen membrane (Bio-Gide (R), Geistlich Pharma AG, Switzerland) was used in the control group patients, as well as a PEG membrane (Membragel (R), Institut Straumann AG, Switzerland) in the study group. After 6 months, the samples were collected during implant site preparation for histopathological evaluation. Results: There were no statistically significant differences between the control and the study groups in the histological examination regarding the soft-to-hard tissue ratio. There was no statistically significant difference between the control and study groups in the resonance frequency analysis measurements at different times. No postoperative inflammation or exposure of the membrane was observed in any of the patients. The visual analogue scale scores measured at different times also showed no significant difference. Conclusion: A PEG membrane can be used as an alternative to a collagen membrane as a barrier in sinus floor augmentation procedures.